(J70.3) Chronic drug-induced interstitial lung disorders

More details coming soon

Icon
99 238 in individuals diagnosis chronic drug-induced interstitial lung disorders confirmed
Icon
5 233 deaths with diagnosis chronic drug-induced interstitial lung disorders
Icon
5% mortality rate associated with the disease chronic drug-induced interstitial lung disorders

Diagnosis chronic drug-induced interstitial lung disorders is diagnosed Men are 3.52% more likely than Women

51 367

Men receive the diagnosis chronic drug-induced interstitial lung disorders

2 686 (5.2 %)

Died from this diagnosis.

100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
47 871

Women receive the diagnosis chronic drug-induced interstitial lung disorders

2 547 (5.3 %)

Died from this diagnosis.

Risk Group for the Disease chronic drug-induced interstitial lung disorders - Men aged 70-74 and Women aged 80-84

Icon
In Men diagnosis is most often set at age 0-94
Icon
Less common in men the disease occurs at Age 95+Less common in women the disease occurs at Age 25-29
Icon
In Women diagnosis is most often set at age 0-24, 30-95+

Disease Features chronic drug-induced interstitial lung disorders

Icon
Absence or low individual and public risk
Icon

Chronic drug-induced interstitial lung disorders - what does this mean

Chronic drug-induced interstitial lung disorders occur when an individual is exposed to a drug or medication for an extended period of time, causing inflammation and scarring in the lungs. this can lead to impaired lung function, shortness of breath, and other respiratory symptoms.

What happens during the disease - chronic drug-induced interstitial lung disorders

Chronic drug-induced interstitial lung disorders are caused by a prolonged exposure to certain drugs, which leads to inflammation and damage of the lung tissue. this damage can cause a variety of symptoms, including difficulty breathing, wheezing, coughing, chest tightness, and fatigue. over time, the inflammation can lead to scarring of the lung tissue, resulting in a decrease in lung function and an increased risk of developing other respiratory illnesses.

Clinical Pattern

More details coming soon

How does a doctor diagnose

  • Complete physical examination
  • Chest X-ray
  • Spirometry
  • CT scan
  • Bronchoscopy
  • Lung biopsy
  • Blood tests
  • Pulmonary function tests
  • Pulse oximetry

Treatment and Medical Assistance

Main goal of the treatment: To reduce inflammation and improve lung function.
  • Avoiding exposure to environmental and occupational pollutants
  • Managing underlying diseases, such as diabetes, asthma, and COPD
  • Treating underlying infections, such as pneumonia
  • Stopping the use of drugs that may be causing the condition
  • Using corticosteroids to reduce inflammation
  • Using bronchodilators to open the airways
  • Using antibiotics to treat infections
  • Using oxygen therapy to improve oxygen levels
  • Using pulmonary rehabilitation to improve lung function
  • Using immunosuppressant drugs to reduce inflammation
  • Using surgery to remove scar tissue from the lungs
Icon
20 Days of Hospitalization Required
Icon
Average Time for Outpatient Care Not Established

Chronic drug-induced interstitial lung disorders - Prevention

The best way to prevent chronic drug-induced interstitial lung disorders is to avoid the use of drugs that can lead to this disorder. some drugs, such as amiodarone, can cause this disorder, so it is important to be aware of the potential risks associated with any drug before taking it. in addition, it is important to monitor lung function regularly and to seek medical attention if any changes in breathing or other symptoms occur.